
Bombay HC restrains sale of ‘CEFDON’ cough syrup, cites deceptive similarity with ‘CEDON’
The Hindu
Bombay HC halts 'CEFDON' cough syrup sales, citing deceptive similarity to 'CEDON', ordering ₹10 lakh in costs to Blue Cross.
More Related News

The draft policy for “Responsible Digital Use Among Students”, released on Monday by the Department of Health and Family Welfare, has recommended that parents set structured routines with clear screen-time rules and prioritise privacy, safety, and open conversation with children on digital well-being.












